Advertisement
Advertisement
U.S. Markets open in 7 hrs 50 mins
Advertisement
Advertisement
Advertisement
Advertisement

Qualigen Therapeutics, Inc. (QLGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
0.5200+0.0152 (+3.01%)
At close: 04:00PM EDT
0.5355 +0.02 (+2.98%)
After hours: 07:32PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.1200
52 Week Low 30.4500
50-Day Moving Average 30.6072
200-Day Moving Average 31.0252

Share Statistics

Avg Vol (3 month) 31.2M
Avg Vol (10 day) 3232.08k
Shares Outstanding 535.29M
Implied Shares Outstanding 6N/A
Float 835.06M
% Held by Insiders 112.67%
% Held by Institutions 18.23%
Shares Short (Apr 28, 2022) 41.24M
Short Ratio (Apr 28, 2022) 40.43
Short % of Float (Apr 28, 2022) 43.56%
Short % of Shares Outstanding (Apr 28, 2022) 43.50%
Shares Short (prior month Mar 30, 2022) 41.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 25, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3May 25, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-301.80%

Management Effectiveness

Return on Assets (ttm)-41.05%
Return on Equity (ttm)-102.68%

Income Statement

Revenue (ttm)5.65M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)33.70%
Gross Profit (ttm)-4.8M
EBITDA -16.95M
Net Income Avi to Common (ttm)-17.9M
Diluted EPS (ttm)-0.3400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.54M
Total Cash Per Share (mrq)0.5
Total Debt (mrq)1.68M
Total Debt/Equity (mrq)10.12
Current Ratio (mrq)4.49
Book Value Per Share (mrq)0.37

Cash Flow Statement

Operating Cash Flow (ttm)-14.73M
Levered Free Cash Flow (ttm)-9.33M
Advertisement
Advertisement